Find uplifting stories about heroes, innovations, and solutions
63 results for "drug development"
Scientists just got a powerful new research partner that could cut years off drug development timelines. OpenAI's GPT-Rosalind, named after DNA pioneer Rosalind Franklin, is the first AI model built specifically to accelerate biology and medicine breakthroughs.
OpenAI just launched GPT-Rosalind, an AI model designed to speed up the painfully slow process of bringing new medicines to patients. With drug development currently taking 10 to 15 years, this breakthrough could help researchers find cures faster.
Scientists at the University of Utah have discovered an enzyme that transforms peptide drugs like Ozempic into longer-lasting forms. The breakthrough could help medications stay effective in the body for hours instead of minutes.
A new platform is putting cutting-edge AI into the hands of biologists who want to design life-saving treatments but don't know how to code. OpenProtein.AI offers free access to powerful protein-engineering tools that could speed up drug development for everyone.
OpenAI just released GPT-Rosalind, an AI designed to help scientists discover life-saving drugs faster. With 300 million people worldwide waiting for treatments for rare diseases, this tool could cut years off the typical 10-15 year drug development timeline.
While expensive new Alzheimer's drugs grab headlines, doctors reveal that existing affordable medications work twice as well but only half of patients receive them. Researchers are now combining different approaches that could finally stop the disease.
A team developing light-activated cancer drugs just won $2 million for showing how quantum computers could revolutionize medicine. The breakthrough brings us closer to treatments that target tumors without harming healthy cells.
A breakthrough drug called daraxonrasib has shown it can extend survival in pancreatic cancer patients, one of medicine's toughest challenges. The announcement from Revolution Medicines marks what experts are calling a new era in treating this devastating disease.
University of Virginia scientists created AI tools that design drugs while treating proteins as flexible, living structures instead of frozen snapshots. This breakthrough could slash the 90% failure rate in drug development and bring new treatments to patients faster.
University of Virginia researchers created AI tools that could transform how quickly life-saving medications reach patients. Their system designs drugs by simulating how proteins actually move in the body, not just frozen snapshots.
The FDA is rolling out new proposals to encourage pharmaceutical companies to test and manufacture medicines right here in the United States. The moves could help reduce America's dependence on foreign drug supplies while creating jobs at home.
Scientists used artificial intelligence to create a new compound that reduces opioid addiction in rats without the side effects or stigma of current treatments. The breakthrough could offer millions of people struggling with addiction a path to recovery that doesn't involve replacing one opioid with another.
A Ghanaian scientist at Imperial College London is using microchip technology smaller than your phone to speed up medicine development for diseases like malaria and diabetes. The breakthrough could cut years off traditional drug testing while reducing costs and animal testing.
Hong Kong-based Insilico Medicine just landed a potential $2.75 billion partnership with pharmaceutical giant Eli Lilly, marking one of the largest AI drug development deals ever. The agreement shows how artificial intelligence is transforming medicine from science fiction into life-saving reality.
AI drug developer Insilico Medicine just landed a massive partnership with pharma giant Eli Lilly worth up to $2.75 billion. The deal could accelerate how new medicines reach patients who need them.
China's rapidly growing biotech sector is transforming how new medicines reach patients worldwide. The expansion signals more resources, faster innovation, and greater competition in the race to cure diseases.
Researchers discovered how a tiny cellular channel prevents toxic buildup in brain cells, opening a promising new path to treat Parkinson's disease. The breakthrough solves a mystery scientists have puzzled over for years.
Researchers have discovered how a tiny cellular protein acts like a safety valve, preventing toxic buildup that contributes to Parkinson's disease. This breakthrough could lead to new treatments for millions living with neurodegenerative conditions.
After a difficult year, biotech company Sarepta Therapeutics is bouncing back with early clinical trial results showing two new muscular dystrophy treatments appear safe and effective. The promising data offers hope for patients with rare muscle-wasting diseases who desperately need new treatment options.
Researchers discovered a deadly protein pairing that kills brain cells in Alzheimer's patients and created a drug that stops it. The treatment preserved memory and learning in mice while reducing toxic brain deposits.
Showing 20 of 63